Goldman Sachs Raises Abivax Stake to 5.55%, Crossing 5% Threshold
Goldman Sachs crossed above 5% of Abivax’s capital and voting rights on September 28, 2026, through an off-market share acquisition. Its indirect holding reached 4,840,036 shares, representing 5.55% of capital and 5.47% of voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using genera